The a2 Milk Company Limited reported a 12.4% increase in revenue for FY26, reaching $1,974.9 million. This growth was primarily driven by the English label Infant Milk Formula (IMF), Other Nutritionals, and Liquid Milk, despite a decline in China label IMF sales due to supply chain disruptions that have since been resolved. The ANZ and USA segments saw notable revenue increases of 10.2% and 28.6% respectively. Marketing investments were increased, particularly in China, to support growth strategies. The EBITDA decreased by 2.5% but the underlying EBITDA rose by 5.4%. Net profit after tax from continuing operations fell by 5.8%. Challenges included significant losses from the a2 Pōkeno facility due to low production volumes and transition costs. The company declared a final dividend of 9.5 cents per share and a special dividend of 41.3 cents per share. Looking ahead to FY27, the company expects revenue growth supported by product innovation and a gradual recovery in China IMF sales.
Key Points
FY26 revenue grew 12.4% to $1,974.9 million, driven by growth in English label IMF, Other Nutritionals, and Liquid Milk.
Supply chain disruptions in 4Q26 affected China label IMF sales, but these issues have been resolved.
ANZ segment revenue increased by 10.2%, mostly due to the growth of Australian liquid milk.
USA segment revenue rose by 28.6% due to increased sales of core and grassfed liquid milk.
Marketing investments were up to support growth strategies, particularly in China.
EBITDA was down 2.5% to $284.4 million, with underlying EBITDA up 5.4% to $307.6 million.
Net profit after tax from continuing operations decreased by 5.8% to $207.5 million.
a2 Pokeno experienced losses due to low production volumes and transition costs.
The company declared a final dividend of 9.5 cents per share and a special dividend of 41.3 cents per share.
FY27 outlook includes expected revenue growth, continued product innovation, and recovery in China IMF sales.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.